Immuron Limited
IMRN
$2.35
$0.146.34%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.73M | 4.51M | 4.32M | 3.78M | 3.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.73M | 4.51M | 4.32M | 3.78M | 3.22M |
| Cost of Revenue | 1.63M | 1.52M | 1.40M | 1.22M | 1.03M |
| Gross Profit | 3.09M | 3.00M | 2.91M | 2.56M | 2.19M |
| SG&A Expenses | 5.13M | 5.12M | 5.12M | 4.74M | 4.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -912.20K | -1.22M | -1.53M | -1.88M | -2.23M |
| Total Operating Expenses | 8.19M | 8.13M | 8.10M | 7.40M | 6.64M |
| Operating Income | -3.46M | -3.61M | -3.78M | -3.61M | -3.42M |
| Income Before Tax | -3.37M | -4.10M | -4.85M | -4.71M | -4.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.37 | -4.10 | -4.85 | -4.71 | -4.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.37M | -4.10M | -4.85M | -4.71M | -4.56M |
| EBIT | -3.46M | -3.61M | -3.78M | -3.61M | -3.42M |
| EBITDA | -3.45M | -3.60M | -3.76M | -3.59M | -3.41M |
| EPS Basic | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 923.75M | 918.32M | 912.90M | 912.17M | 911.44M |
| Average Diluted Shares Outstanding | 923.75M | 918.32M | 912.90M | 912.17M | 911.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |